Overcoming EGFR (T790M) and EGFR (C797S) resistance with mutant-selective allosteric inhibitors Y Jia, CH Yun, E Park, D Ercan, M Manuia, J Juarez, C Xu, K Rhee, ... Nature 534 (7605), 129-132, 2016 | 804 | 2016 |
Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors J Zhang, FJ Adrián, W Jahnke, SW Cowan-Jacob, AG Li, RE Iacob, T Sim, ... Nature 463 (7280), 501-506, 2010 | 693 | 2010 |
Comparative study of several algorithms for flexible ligand docking BD Bursulaya, M Totrov, R Abagyan, CL Brooks Journal of computer-aided molecular design 17, 755-763, 2003 | 512 | 2003 |
Synthesis, Structure–Activity Relationships, and in Vivo Efficacy of the Novel Potent and Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor 5-Chloro-N2-(2-isopropoxy-5 … TH Marsilje, W Pei, B Chen, W Lu, T Uno, Y Jin, T Jiang, S Kim, N Li, ... Journal of medicinal chemistry 56 (14), 5675-5690, 2013 | 448 | 2013 |
Targeting Plasmodium PI(4)K to eliminate malaria CW McNamara, MCS Lee, CS Lim, SH Lim, J Roland, A Nagle, O Simon, ... Nature 504 (7479), 248-253, 2013 | 446 | 2013 |
Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness S Khare, AS Nagle, A Biggart, YH Lai, F Liang, LC Davis, SW Barnes, ... Nature 537 (7619), 229-233, 2016 | 409 | 2016 |
Identification of transmembrane domain 5 as a critical molecular determinant of menthol sensitivity in mammalian TRPA1 channels B Xiao, AE Dubin, B Bursulaya, V Viswanath, TJ Jegla, A Patapoutian Journal of Neuroscience 28 (39), 9640-9651, 2008 | 346 | 2008 |
Design, synthesis and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Part I T Jiang, KL Kuhen, K Wolff, H Yin, K Bieza, J Caldwell, B Bursulaya, ... Bioorganic & medicinal chemistry letters 16 (8), 2105-2108, 2006 | 299 | 2006 |
Golgicide A reveals essential roles for GBF1 in Golgi assembly and function JB Saenz, WJ Sun, JW Chang, J Li, B Bursulaya, NS Gray, DB Haslam Nature chemical biology 5 (3), 157-165, 2009 | 254 | 2009 |
Design, synthesis, and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Part 2 T Jiang, KL Kuhen, K Wolff, H Yin, K Bieza, J Caldwell, B Bursulaya, ... Bioorganic & medicinal chemistry letters 16 (8), 2109-2112, 2006 | 251 | 2006 |
Gene expression signatures and small-molecule compounds link a protein kinase to Plasmodium falciparum motility N Kato, T Sakata, G Breton, KG Le Roch, A Nagle, C Andersen, ... Nature chemical biology 4 (6), 347-356, 2008 | 249 | 2008 |
Temperature-induced opening of TRPV1 ion channel is stabilized by the pore domain J Grandl, SE Kim, V Uzzell, B Bursulaya, M Petrus, M Bandell, ... Nature neuroscience 13 (6), 708-714, 2010 | 247 | 2010 |
In vivo Incorporation of Unnatural Amino Acids to Probe Structure, Dynamics, and Ligand Binding in a Large Protein by Nuclear Magnetic Resonance Spectroscopy SE Cellitti, DH Jones, L Lagpacan, X Hao, Q Zhang, H Hu, SM Brittain, ... Journal of the American Chemical Society 130 (29), 9268-9281, 2008 | 238 | 2008 |
Discovery of tropifexor (LJN452), a highly potent non-bile acid FXR agonist for the treatment of cholestatic liver diseases and nonalcoholic steatohepatitis (NASH) DC Tully, PV Rucker, D Chianelli, J Williams, A Vidal, PB Alper, D Mutnick, ... Journal of medicinal chemistry 60 (24), 9960-9973, 2017 | 222 | 2017 |
Selective incorporation of 5-hydroxytryptophan into proteins in mammalian cells Z Zhang, L Alfonta, F Tian, B Bursulaya, S Uryu, DS King, PG Schultz Proceedings of the National Academy of Sciences 101 (24), 8882-8887, 2004 | 207 | 2004 |
Pore region of TRPV3 ion channel is specifically required for heat activation J Grandl, H Hu, M Bandell, B Bursulaya, M Schmidt, M Petrus, ... Nature neuroscience 11 (9), 1007-1013, 2008 | 182 | 2008 |
Development and characterization of nonpeptidic small molecule inhibitors of the XIAP/caspase-3 interaction TYH Wu, KW Wagner, B Bursulaya, PG Schultz, QL Deveraux Chemistry & biology 10 (8), 759-767, 2003 | 175 | 2003 |
Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197 E Malito, B Bursulaya, C Chen, PL Surdo, M Picchianti, E Balducci, ... Proceedings of the National Academy of Sciences 109 (14), 5229-5234, 2012 | 171 | 2012 |
EGF816 exerts anticancer effects in non–small cell lung cancer by irreversibly and selectively targeting primary and acquired activating mutations in the EGF receptor Y Jia, J Juarez, J Li, M Manuia, MJ Niederst, C Tompkins, N Timple, ... Cancer research 76 (6), 1591-1602, 2016 | 129 | 2016 |
Folding free energy surface of a three-stranded β-sheet protein BD Bursulaya, CL Brooks Journal of the American Chemical Society 121 (43), 9947-9951, 1999 | 120 | 1999 |